FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3191009683> ?p ?o ?g. }

• W3191009683 endingPage "605" @default.
• W3191009683 startingPage "599" @default.
• W3191009683 abstract "ABSTRACT: Solubility and permeability are one of the main factors that regulate the rate and extent of drug absorption, where this factors affect drug bioavailability. Low drug solubility and permeability resulting in low drug bioavailability. To overcome this, modifications of the delivery system of the drugs can be made, such as Solid Lipid Nanoparticles (SLN). SLN is a colloidal carrier consist of solid lipid and surfactant. The purpose of this review was to examine the SLN formula based on the solid lipid and surfactant, the preparation methods of SLN, and the characterization of SLN to improve drug bioavailability. Results of this review are: (1) In formulation of SLN the most important things to do are lipid screening based on the solubility of the drug in lipids and surfactant screening based on its ability to disperse lipids in the aqueous phase.  (2) The selection of SLN preparation methods is based on the physical properties of the drugs such as thermal properties and solubility. (3) The ideal characterizations of SLN are particle size between 50 – 1000 nm, zeta potential value ± 30 mV, polydispersity index value is ˂0,7, and percent of entrapment efficiency is around 40 – 100%. Keywords: Solid Lipid Nanoparticles, Formulation, Bioavailability ABSTRAK: Kelarutan dan permeabilitas adalah salah satu faktor utama yang mengatur laju dan tingkat penyerapan obat, dimana faktor tersebut mempengaruhi bioavailabilitas obat. Kelarutan dan atau permeabilitas yang rendah menyebabkan bioavaialabilitas yang rendah. Salah satu cara untuk meningkatkan bioavailabilitas obat adalah dengan memodifikasi sistem penghantaran obat, contohnya yaitu Solid Lipid Nanoparticles (SLN). SLN merupakan pembawa koloidal yang mengandung lipid padat dan surfaktan. Tujuan dari kajian ini adalah untuk mengkaji formula SLN ditinjau dari lipid padat dan surfaktannya, metode pembuatan SLN, dan karakterisasi SLN untuk meningkatkan bioavailabilitas obat. Hasil dari kajian ini adalah: (1) Pada formulasi SLN hal yang paling penting dilakukan adalah melakukan skrining lipid berdasarkan kelarutan zat aktif dalam lipid dan skrining surfaktan berdasarkan kemampuannya untuk mendispersikan lipid dalam fase air. (2) Pemilihan metode pembuatan SLN disesuaikan dengan sifat fisika dari zat aktif seperti sifat termal dan kelarutannya. (3) Karakterisasi SLN yang baik yaitu ukuran partikel 50 – 1000 nm, potensial zeta ± 30 mV, indeks polidispersitas ˂0,7, dan persen efisiensi penjerapan sekitar berkisar 40 – 100%. Kata Kunci: Solid Lipid Nanoparticles, Formulasi, Bioavailabilitas" @default.
• W3191009683 created "2021-08-16" @default.
• W3191009683 creator A5056464231 @default.
• W3191009683 creator A5087003916 @default.
• W3191009683 creator A5091289700 @default.
• W3191009683 date "2021-08-02" @default.
• W3191009683 modified "2023-09-24" @default.
• W3191009683 title "Studi Literatur Formulasi dan Karakterisasi Solid Lipid Nanoparticles (SLN) untuk Meningkatkan Bioavailabilitas Obat" @default.
• W3191009683 doi "https://doi.org/10.29313/.v0i0.29977" @default.
• W3191009683 hasPublicationYear "2021" @default.
• W3191009683 type Work @default.
• W3191009683 sameAs 3191009683 @default.
• W3191009683 citedByCount "0" @default.
• W3191009683 crossrefType "journal-article" @default.
• W3191009683 hasAuthorship W3191009683A5056464231 @default.
• W3191009683 hasAuthorship W3191009683A5087003916 @default.
• W3191009683 hasAuthorship W3191009683A5091289700 @default.
• W3191009683 hasConcept C11432220 @default.
• W3191009683 hasConcept C147789679 @default.
• W3191009683 hasConcept C155574463 @default.
• W3191009683 hasConcept C155672457 @default.
• W3191009683 hasConcept C171250308 @default.
• W3191009683 hasConcept C178790620 @default.
• W3191009683 hasConcept C181389837 @default.
• W3191009683 hasConcept C18150654 @default.
• W3191009683 hasConcept C185592680 @default.
• W3191009683 hasConcept C187530423 @default.
• W3191009683 hasConcept C192562407 @default.
• W3191009683 hasConcept C199529486 @default.
• W3191009683 hasConcept C2779820397 @default.
• W3191009683 hasConcept C43617362 @default.
• W3191009683 hasConcept C55493867 @default.
• W3191009683 hasConcept C58226133 @default.
• W3191009683 hasConcept C71924100 @default.
• W3191009683 hasConcept C86181022 @default.
• W3191009683 hasConcept C98274493 @default.
• W3191009683 hasConceptScore W3191009683C11432220 @default.
• W3191009683 hasConceptScore W3191009683C147789679 @default.
• W3191009683 hasConceptScore W3191009683C155574463 @default.
• W3191009683 hasConceptScore W3191009683C155672457 @default.
• W3191009683 hasConceptScore W3191009683C171250308 @default.
• W3191009683 hasConceptScore W3191009683C178790620 @default.
• W3191009683 hasConceptScore W3191009683C181389837 @default.
• W3191009683 hasConceptScore W3191009683C18150654 @default.
• W3191009683 hasConceptScore W3191009683C185592680 @default.
• W3191009683 hasConceptScore W3191009683C187530423 @default.
• W3191009683 hasConceptScore W3191009683C192562407 @default.
• W3191009683 hasConceptScore W3191009683C199529486 @default.
• W3191009683 hasConceptScore W3191009683C2779820397 @default.
• W3191009683 hasConceptScore W3191009683C43617362 @default.
• W3191009683 hasConceptScore W3191009683C55493867 @default.
• W3191009683 hasConceptScore W3191009683C58226133 @default.
• W3191009683 hasConceptScore W3191009683C71924100 @default.
• W3191009683 hasConceptScore W3191009683C86181022 @default.
• W3191009683 hasConceptScore W3191009683C98274493 @default.
• W3191009683 hasLocation W31910096831 @default.
• W3191009683 hasOpenAccess W3191009683 @default.
• W3191009683 hasPrimaryLocation W31910096831 @default.
• W3191009683 isParatext "false" @default.
• W3191009683 isRetracted "false" @default.
• W3191009683 magId "3191009683" @default.
• W3191009683 workType "article" @default.